Analysis of Debt
Paying user area
Try for free
Bristol-Myers Squibb Co. pages available for free this week:
- Statement of Comprehensive Income
- Balance Sheet: Liabilities and Stockholders’ Equity
- Cash Flow Statement
- Common-Size Balance Sheet: Assets
- Analysis of Solvency Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Price to FCFE (P/FCFE)
- Dividend Discount Model (DDM)
- Net Profit Margin since 2005
- Debt to Equity since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Bristol-Myers Squibb Co. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Total Debt (Carrying Amount)
Bristol-Myers Squibb Co., balance sheet: debt
US$ in millions
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Short-term debt obligations | ||||||
| Long-term debt, excluding current portion | ||||||
| Total debt (carrying amount) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
- Short-term debt obligations
- There is a marked fluctuation in short-term debt obligations over the five-year period. The value nearly doubled from approximately 2,340 million USD in 2020 to nearly 4,948 million USD in 2021, indicating a significant increase in short-term borrowings or liabilities due within a year. Subsequently, this figure declined steadily over the following years, reaching 2,046 million USD by the end of 2024. This trend suggests a reduction in short-term debt exposure after the peak in 2021, which could reflect efforts to manage liquidity or refinancing strategies.
- Long-term debt, excluding current portion
- The long-term debt shows a declining trend from 48,336 million USD at the end of 2020 to a low of 35,056 million USD by the end of 2022. This indicates a substantial reduction in long-term liabilities during this period. However, starting in 2023, the long-term debt began to increase again, reaching 47,603 million USD by the end of 2024. This rebound suggests new borrowing or debt restructuring activities, possibly to support investments or capital expenditures after a period of deleveraging.
- Total debt (carrying amount)
- Total debt reflects a similar pattern to the underlying short-term and long-term debt components. It shows a decrease from 50,676 million USD in 2020 to 39,320 million USD in 2022, indicating an overall reduction in debt levels during this timeframe. From 2023 onwards, total debt increases again to 49,649 million USD by the end of 2024, nearly reaching the 2020 level. This suggests a cyclical pattern of debt management, with initial reduction followed by increased borrowing within the observed period.
Total Debt (Fair Value)
| Dec 31, 2024 | |
|---|---|
| Selected Financial Data (US$ in millions) | |
| Short-term borrowings | |
| Long-term debt, including current portion | |
| Total debt (fair value) | |
| Financial Ratio | |
| Debt, fair value to carrying amount ratio | |
Based on: 10-K (reporting date: 2024-12-31).
Weighted-average Interest Rate on Debt
Weighted-average interest rate on debt:
| Interest rate | Debt amount1 | Interest rate × Debt amount | Weighted-average interest rate2 |
|---|---|---|---|
| Total | |||
Based on: 10-K (reporting date: 2024-12-31).
1 US$ in millions
2 Weighted-average interest rate = 100 × ÷ =